ARTICLE | Company News
Kineta, University of Washington, University of Texas Medical Branch infectious news
May 14, 2012 7:00 AM UTC
The NIH's National Institute of Allergy and Infectious Diseases (NIAID) granted the universities and Kineta an $8.1 million grant to develop drugs against viral pathogens, including Ebola, plague, Jap...